A (2alpha,5alpha,17beta)-2-methyl-3-oxoandrostan-17-yl propanoate DMF (Drug Master File) is a document detailing the whole manufacturing process of (2alpha,5alpha,17beta)-2-methyl-3-oxoandrostan-17-yl propanoate active pharmaceutical ingredient (API) in detail. Different forms of (2alpha,5alpha,17beta)-2-methyl-3-oxoandrostan-17-yl propanoate DMFs exist exist since differing nations have different regulations, such as (2alpha,5alpha,17beta)-2-methyl-3-oxoandrostan-17-yl propanoate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A (2alpha,5alpha,17beta)-2-methyl-3-oxoandrostan-17-yl propanoate DMF submitted to regulatory agencies in the US is known as a USDMF. (2alpha,5alpha,17beta)-2-methyl-3-oxoandrostan-17-yl propanoate USDMF includes data on (2alpha,5alpha,17beta)-2-methyl-3-oxoandrostan-17-yl propanoate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The (2alpha,5alpha,17beta)-2-methyl-3-oxoandrostan-17-yl propanoate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of (2alpha,5alpha,17beta)-2-methyl-3-oxoandrostan-17-yl propanoate suppliers with USDMF on PharmaCompass.